| ²é¿´: 947 | »Ø¸´: 12 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
sysboyľ³æ (ÖøÃûдÊÖ)
ÖÁ×ðľ³æ(ÎÄ̳¾«Ó¢)
|
[½»Á÷]
Elsevier ¹«²¼ÆìÏÂÆÚ¿¯2008ÄêÓ°ÏìÒò×ÓÇé¿ö
|
||
|
51ÖÖElsevierÆÚ¿¯ÃûÁÐǰ飬ÏÔʾÁËÒ»Èç¼ÈÍùµÄ¸ßÖÊÁ¿ °¢Ä·Ë¹Ìص¤£¬2009Äê6ÔÂ29ÈÕѶ¡ª¡ª½üÈÕ£¬È«Çò×î´óµÄ¿ÆÑ§¼¼Êõ¼°Ò½Ñ§ÐÅÏ¢²úÆ·¼°·þÎñÌṩÉÌElsevier¹«²¼ÁË2008ÄêÆìÏÂÆÚ¿¯µÄÓ°ÏìÒò×Ó±íÏÖÇé¿ö¡£´Ó2007Äêµ½2008Ä꣬75%µÄElsevierÆÚ¿¯Ó°ÏìÒò×Ó¶¼»ñµÃÁËÌáÉý¡£¸ù¾ÝÌÀÄ·É¡¤Â·Í¸¹«Ë¾·¢²¼µÄ2008Äê¡¶ÆÚ¿¯ÒýÖ¤±¨¸æ¡·(Journal Citation Reports)£¬ÔÚº¸ÇÁË×ÔÈ»¿ÆÑ§ºÍÉç»á¿ÆÑ§µÄËùÓÐ229¸öѧ¿Æ·ÖÀàÖУ¬ElsevierÆÚ¿¯ÔÚ51¸öѧ¿ÆÖеÄÅÅÃûµÚÒ»¡£ ³ý´ËÖ®Í⣬30ÖÖElsevier ÆÚ¿¯ÔÚ2008ÄêµÚÒ»´ÎÓµÓÐÁË×Ô¼ºµÄÓ°ÏìÒò×Ó¡£ÕâЩÆÚ¿¯ÖÐÓеÄÈ¡µÃÁ˷dz£ÏÔÖøµÄ³É¼¨£¬Ëü°üÀ¨Á½ÖÖCell³ö°æÉçµÄÆÚ¿¯£º¡¶Ï¸°û¡ª¡ª¸Éϸ°û¡·£¨Cell Stem Cell (http://www.cell.com/cell-stem-cell/home£¬Ó°ÏìÒò×ÓÊÇ16.826)ÔÚ¡°Ï¸°ûÉúÎïѧÀà±ð¡±µÄ157ÖÖÆÚ¿¯ÖÐÅÅÃûµÚ6£¬¶ø¡¶Ï¸°û¡ª¡ªËÞÖ÷Óë΢ÉúÎï¡·£¨Cell Host & Microbe £¬http://www.cell.com/cell-stem-cell/home£¬Ó°ÏìÒò×ÓÊÇ7.436£©ÔÚ¡°Î¢ÉúÎïÀࡱµÄ91ÖÐÆÚ¿¯ÖÐÅÅÃûµÚ10¡£ÁíÒ»¸öµÚÒ»ÄêÈëÑ¡JCR¾ÍÈ¡µÃºÃ³É¼¨µÄÆÚ¿¯ÊÇ¡¶½ñÈÕ²ÄÁÏ¡·£¨Materials Today £¬http://www.materialstoday.com/£¬Ó°ÏìÒò×ÓÊÇ12.929), ËüÔÚ¡°¶àѧ¿ÆÀà±ð¡ª¡ª²ÄÁÏ¿ÆÑ§¡±ÖеÄ191ÖÖÆÚ¿¯ÖÐÅÅÃûµÚ4. 182ÖÖElsevier ÆÚ¿¯µÄÓ°ÏìÒò×Ó±È2007ÄêÌá¸ßÁË50%¶à¡£¡¶ÁøÒ¶µ¶¡·ÆìϵÄÈýÖÖרҵÆÚ¿¯µÄÓ°ÏìÒò×ÓÈ«²¿Ìá¸ß¡£¡¶ÁøÒ¶µ¶¡ª¡ª´«È¾²¡¡·£¨Lancet Infectious Diseases£¬http://www.thelancet.com/journals/laninf/issue/current£©µÄÓ°ÏìÒò×ÓÌá¸ßÖÁ13.165£¬ÔÚ¡°´«È¾²¡¡±Àà±ðÖаεÃÍ·³ï¡£¡¶ÁøÒ¶µ¶¡ª¡ªÖ×Áö¡·£¨Lancet Oncology£¬http://www.thelancet.com/journals/lanonc/issue/current£©µÄÓ°ÏìÒò×ÓÌá¸ßÖÁ13.283,£¬±È2007ÄêµÄÊýÖµÕûÕûÌá¸ßÁË1µã¶à¡£×îºó£¬¡¶ÁøÒ¶µ¶¡ª¡ªÉñ¾²¡Ñ§¡·£¨Lancet Neurology£¬http://www.thelancet.com/journals/laneur/issue/current£©µÄÓ°ÏìÒò×ÓÌá¸ßÁË40%£¬´ïµ½ÁË14.270£¬´Ó¶øÁ¬Ðø5Äê²õÁªÁË¡°ÁÙ´²Éñ¾²¡Ñ§¡±ÀàÖеĵÚÒ»Ãû¡£ ÆäËûElsevierÆÚ¿¯µÄÓ°ÏìÒò×ÓÒ²ÊÇÖðÄêµÝÔö£¬ÓÈÆäÊÇ¡¶ÉúÎï²ÄÁÏ¡·£¨Biomaterials£¬http://www.elsevier.com/locate/biomaterials£©£¬´Ë¿¯µÄÓ°ÏìÒò×Ó×Ô2003ÄêÒÔÀ´²»¶ÏÌáÉý¡£¡¶¹ýÃô¼°ÁÙ´²ÃâÒßѧÔÓÖ¾¡·£¨The Journal of Allergy and Clinical Immunology£¬http://www.elsevier.com/locate/jaci£©ÔÚ¹ýÈ¥ÎåÄêÀïÓ°ÏìÒò×Ó³ÖÐøÔö³¤¡£ Elsevier¸ºÔðÃÀ¹úҽѧÆÚ¿¯µÄ¸ß¼¶¸±×ܲÃGlen Campbell˵£¬¡°Ã¿Ò»Äê¶È¹«²¼µÄÓ°ÏìÒò×Ó¶¼Ö¤Ã÷ÁËÎÒÃÇÔÚҽѧÆÚ¿¯³ö°æ·½ÃæµÄÁìÏȵØÎ»ºÍ׿Խ±íÏÖ¡£½ñÄ꣬Èç´Ë¶àÆÚ¿¯µÄÓÅÒì±íÏÖ¸üÊǼûÖ¤ÁËÎÒÃÇÓëÆÚ¿¯±àί¡¢¸÷Ààѧ»áµÄÃÜÇкÏ×÷£¬Ó°ÏìÒò×ÓµÄÔö³¤ÊÇÎÒÃÇÐÁÇÚ¹¤×÷¡¢Í¨Á¦ºÏ×÷¡¢×¢ÖØÖÊÁ¿µÄ½á¹û¡£¡± ¡°ÕâÒ»ÊÂʵ²»½ö˵Ã÷ElsevierÊÇÕâ¸öÐÐÒµÖÐÕûÌåÒµ¼¨×îºÃµÄÒ»¸ö£¬Í¬Ê±Ò²Ö¤ÊµÁ˹ýÈ¥ÈýÄê¼äÎÒÃÇÒ»Ö±¶ÔÆÚ¿¯ÖÊÁ¿µÄÖØÊÓ¡£Ó°ÏìÒò×ÓµÄÌá¸ßÒ²Ö¤Ã÷ÁËÎÒÃÇÆÚ¿¯ÉÏ·¢±íµÄÊÇ×î¸ßÖÊÁ¿µÄÑо¿³É¹û¡£¡±Elsevier ¿Æ¼¼ÆÚ¿¯³ö°æÖ´ÐжÊÂMartin Tanke˵µÀ£¬¡°ÎÒÃÇÒª¸ÐлÓëÎÒÃÇͨÁ¦ºÏ×÷µÄÄÇЩÄܸɵıà¼ÃÇ£¬ÊÇËûÃÇÿÌìÓëÎÒÃÇÒ»Æð¸ûÔÅÕâЩÔÓÖ¾£¬Ê¹Ö®³ÉΪͬÁìÓòÖÐ×îºÃµÄÆÚ¿¯¡£¡± Ó°ÏìÒò×ÓÊÇÒ»ÖÖºâÁ¿·½·¨£¬¼ÆËãÔÚij¸öÆÚ¿¯ÉÏ·¢±íµÄÎÄÕÂÔÚÌØ¶¨Äê·ÝÄÚ±»ÒýÓÃµÄÆµÂÊ¡£ËüÊǺâÁ¿Í¬Ò»ÁìÓòÄÚÆÚ¿¯Ïà¶ÔÖÊÁ¿µÄÖ÷Òª²Î¿¼Ö¸±ê¡£ http://www.sciencenet.cn/elsevier/content.aspx?cn=1&id=348 |
» ²ÂÄãϲ»¶
²ÄÁÏ»¯¹¤340Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸ÏÃÃÅ´óѧ²ÄÁϹ¤³Ìר˶354ÕÒµ÷¼Á£¡£¡£¡
ÒѾÓÐ6È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
Ò»Ö¾Ô¸085600ÖпÆÔºÄþ²¨Ëù276·ÖÇóµ÷¼Á
ÒѾÓÐ24È˻ظ´
Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358
ÒѾÓÐ4È˻ظ´
0856²ÄÁÏÓ뻯¹¤µ÷¼Á£¬339
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸Ö£´ó²ÄÁϹ¤³Ì290Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
266·Ö£¬Ò»Ö¾Ô¸µçÆø¹¤³Ì£¬±¾¿Æ²ÄÁÏ£¬Çó²ÄÁÏרҵµ÷¼Á
ÒѾÓÐ9È˻ظ´
372·Ö²ÄÁÏÓ뻯¹¤£¨085600£©Ò»Ö¾Ô¸ºþÄÏ´óѧÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸ÄÏʦ´ó0703»¯Ñ§ 275Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

nono2009
³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)
No gains, no pains.
-

ר¼Ò¾Ñé: +21105 - SEPI: 10
- Ó¦Öú: 28684 (Ժʿ)
- ¹ó±ö: 513.911
- ½ð±Ò: 2555230
- É¢½ð: 27828
- ºì»¨: 2148
- ɳ·¢: 66666
- Ìû×Ó: 1602255
- ÔÚÏß: 65200.9Сʱ
- ³æºÅ: 827383
- ×¢²á: 2009-08-13
- ÐÔ±ð: GG
- רҵ: ¹¤³ÌÈÈÎïÀíÓëÄÜÔ´ÀûÓÃ
- ¹ÜϽ: ¿ÆÑмҳﱸίԱ»á
6Â¥2009-08-29 21:13:22
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
![]() |
2Â¥2009-08-29 16:32:20
lissomchan
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1082.7
- ºì»¨: 2
- Ìû×Ó: 1573
- ÔÚÏß: 95.6Сʱ
- ³æºÅ: 470814
- ×¢²á: 2007-11-30
- ÐÔ±ð: GG
- רҵ: ʳƷ¼Ó¹¤¼¼Êõ
3Â¥2009-08-29 18:18:52
fgt2003
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3223.9
- Ìû×Ó: 616
- ÔÚÏß: 17.8Сʱ
- ³æºÅ: 634836
- ×¢²á: 2008-10-23
- רҵ: ¼ÆËã»úÌåϵ½á¹¹
4Â¥2009-08-29 18:20:58














»Ø¸´´ËÂ¥
